Article summary
Law360: The EU General Court court revived on 31 May 2023 an application by Glaxo Group Ltd to resurrect a trade mark for the shape and colour of asthma inhalers, concluding that the EU Intellectual Property Office (EUIPO) did not properly assess the overall 'distinctiveness' of the trade mark.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial